Companies:
10,793
total market cap:
$134.648 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Clearwater Paper
CLW
#8324
Rank
$0.24 B
Marketcap
๐บ๐ธ
United States
Country
$15.00
Share price
0.94%
Change (1 day)
-38.78%
Change (1 year)
๐ Pulp and paper
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
Clearwater Paper
Quarterly Reports (10-Q)
Submitted on 2022-10-31
Clearwater Paper - 10-Q quarterly report FY
Text size:
Small
Medium
Large
false
2022
Q3
0001441236
December 31
0001441236
2022-01-01
2022-09-30
0001441236
2022-10-28
xbrli:shares
0001441236
2022-09-30
iso4217:USD
0001441236
2021-12-31
iso4217:USD
xbrli:shares
0001441236
2022-07-01
2022-09-30
0001441236
2021-07-01
2021-09-30
0001441236
2021-01-01
2021-09-30
0001441236
2022-06-30
0001441236
2021-06-30
0001441236
2020-12-31
0001441236
2021-09-30
0001441236
us-gaap:CommonStockMember
2020-12-31
0001441236
us-gaap:AdditionalPaidInCapitalMember
2020-12-31
0001441236
us-gaap:RetainedEarningsMember
2020-12-31
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-12-31
0001441236
us-gaap:RetainedEarningsMember
2021-01-01
2021-03-31
0001441236
2021-01-01
2021-03-31
0001441236
us-gaap:AdditionalPaidInCapitalMember
2021-01-01
2021-03-31
0001441236
us-gaap:CommonStockMember
2021-01-01
2021-03-31
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-01-01
2021-03-31
0001441236
us-gaap:CommonStockMember
2021-03-31
0001441236
us-gaap:AdditionalPaidInCapitalMember
2021-03-31
0001441236
us-gaap:RetainedEarningsMember
2021-03-31
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-03-31
0001441236
2021-03-31
0001441236
us-gaap:RetainedEarningsMember
2021-04-01
2021-06-30
0001441236
2021-04-01
2021-06-30
0001441236
us-gaap:AdditionalPaidInCapitalMember
2021-04-01
2021-06-30
0001441236
us-gaap:CommonStockMember
2021-04-01
2021-06-30
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-04-01
2021-06-30
0001441236
us-gaap:CommonStockMember
2021-06-30
0001441236
us-gaap:AdditionalPaidInCapitalMember
2021-06-30
0001441236
us-gaap:RetainedEarningsMember
2021-06-30
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-06-30
0001441236
us-gaap:RetainedEarningsMember
2021-07-01
2021-09-30
0001441236
us-gaap:AdditionalPaidInCapitalMember
2021-07-01
2021-09-30
0001441236
us-gaap:CommonStockMember
2021-07-01
2021-09-30
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-07-01
2021-09-30
0001441236
us-gaap:CommonStockMember
2021-09-30
0001441236
us-gaap:AdditionalPaidInCapitalMember
2021-09-30
0001441236
us-gaap:RetainedEarningsMember
2021-09-30
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-09-30
0001441236
us-gaap:CommonStockMember
2021-12-31
0001441236
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001441236
us-gaap:RetainedEarningsMember
2021-12-31
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-12-31
0001441236
us-gaap:RetainedEarningsMember
2022-01-01
2022-03-31
0001441236
2022-01-01
2022-03-31
0001441236
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-03-31
0001441236
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-01-01
2022-03-31
0001441236
us-gaap:CommonStockMember
2022-03-31
0001441236
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001441236
us-gaap:RetainedEarningsMember
2022-03-31
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-03-31
0001441236
2022-03-31
0001441236
us-gaap:RetainedEarningsMember
2022-04-01
2022-06-30
0001441236
2022-04-01
2022-06-30
0001441236
us-gaap:AdditionalPaidInCapitalMember
2022-04-01
2022-06-30
0001441236
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-04-01
2022-06-30
0001441236
us-gaap:CommonStockMember
2022-06-30
0001441236
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001441236
us-gaap:RetainedEarningsMember
2022-06-30
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-06-30
0001441236
us-gaap:RetainedEarningsMember
2022-07-01
2022-09-30
0001441236
us-gaap:AdditionalPaidInCapitalMember
2022-07-01
2022-09-30
0001441236
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-07-01
2022-09-30
0001441236
us-gaap:CommonStockMember
2022-09-30
0001441236
us-gaap:AdditionalPaidInCapitalMember
2022-09-30
0001441236
us-gaap:RetainedEarningsMember
2022-09-30
0001441236
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-09-30
0001441236
clw:TermLoanMember
2022-09-30
0001441236
clw:TermLoanMember
2021-12-31
0001441236
clw:SeniorNoteDue2025Member
2022-09-30
0001441236
clw:SeniorNoteDue2025Member
2021-12-31
0001441236
clw:SeniorNoteDue2028Member
2022-09-30
0001441236
clw:SeniorNoteDue2028Member
2021-12-31
0001441236
us-gaap:PublicUtilitiesInventoryRawMaterialsMember
2022-09-30
0001441236
us-gaap:PublicUtilitiesInventoryRawMaterialsMember
2021-12-31
0001441236
clw:InventoryPulpMember
2022-09-30
0001441236
clw:InventoryPulpMember
2021-12-31
0001441236
2021-01-01
2021-12-31
xbrli:pure
0001441236
us-gaap:OperatingExpenseMember
clw:MillClosureCostsMember
2022-07-01
2022-09-30
0001441236
us-gaap:OperatingExpenseMember
clw:MillClosureCostsMember
2021-07-01
2021-09-30
0001441236
us-gaap:OperatingExpenseMember
clw:MillClosureCostsMember
2022-01-01
2022-09-30
0001441236
us-gaap:OperatingExpenseMember
clw:MillClosureCostsMember
2021-01-01
2021-09-30
0001441236
us-gaap:OperatingExpenseMember
2022-07-01
2022-09-30
0001441236
us-gaap:OperatingExpenseMember
2021-07-01
2021-09-30
0001441236
us-gaap:OperatingExpenseMember
2022-01-01
2022-09-30
0001441236
us-gaap:OperatingExpenseMember
2021-01-01
2021-09-30
0001441236
srt:DirectorMember
2022-07-01
2022-09-30
0001441236
srt:DirectorMember
2021-07-01
2021-09-30
0001441236
srt:DirectorMember
2022-01-01
2022-09-30
0001441236
srt:DirectorMember
2021-01-01
2021-09-30
0001441236
us-gaap:OperatingExpenseMember
2022-04-01
2022-06-30
0001441236
srt:DirectorMember
2022-04-01
2022-06-30
0001441236
us-gaap:OperatingExpenseMember
clw:MillClosureCostsMember
2022-01-01
2022-03-31
0001441236
srt:DirectorMember
2022-01-01
2022-03-31
0001441236
us-gaap:OperatingExpenseMember
us-gaap:EmployeeSeveranceMember
2021-07-01
2021-09-30
0001441236
us-gaap:OperatingExpenseMember
clw:MillClosureCostsMember
2021-04-01
2021-06-30
0001441236
us-gaap:OperatingExpenseMember
us-gaap:EmployeeSeveranceMember
2021-04-01
2021-06-30
0001441236
srt:DirectorMember
2021-04-01
2021-06-30
0001441236
srt:DirectorMember
2021-01-01
2021-03-31
0001441236
us-gaap:PensionPlansDefinedBenefitMember
2022-07-01
2022-09-30
0001441236
us-gaap:PensionPlansDefinedBenefitMember
2021-07-01
2021-09-30
0001441236
us-gaap:PensionPlansDefinedBenefitMember
2022-01-01
2022-09-30
0001441236
us-gaap:PensionPlansDefinedBenefitMember
2021-01-01
2021-09-30
0001441236
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2022-07-01
2022-09-30
0001441236
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2021-07-01
2021-09-30
0001441236
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2022-01-01
2022-09-30
0001441236
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2021-01-01
2021-09-30
0001441236
us-gaap:CostOfSalesMember
2022-07-01
2022-09-30
0001441236
us-gaap:CostOfSalesMember
2022-01-01
2022-09-30
0001441236
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2022-07-01
2022-09-30
0001441236
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2022-01-01
2022-09-30
0001441236
us-gaap:CostOfSalesMember
2021-07-01
2021-09-30
0001441236
us-gaap:CostOfSalesMember
2021-01-01
2021-09-30
0001441236
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2021-07-01
2021-09-30
0001441236
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2021-01-01
2021-09-30
0001441236
us-gaap:PensionPlansDefinedBenefitMember
2020-12-31
0001441236
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2020-12-31
0001441236
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
us-gaap:PensionPlansDefinedBenefitMember
2021-01-01
2021-09-30
0001441236
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2021-01-01
2021-09-30
0001441236
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2021-01-01
2021-09-30
0001441236
us-gaap:PensionPlansDefinedBenefitMember
2021-09-30
0001441236
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2021-09-30
0001441236
us-gaap:PensionPlansDefinedBenefitMember
2021-12-31
0001441236
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2021-12-31
0001441236
us-gaap:PensionPlansDefinedBenefitMember
2022-09-30
0001441236
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2022-09-30
0001441236
us-gaap:RestrictedStockUnitsRSUMember
2022-01-01
2022-09-30
0001441236
us-gaap:PerformanceSharesMember
2022-01-01
2022-09-30
0001441236
us-gaap:RestrictedStockUnitsRSUMember
2022-07-01
2022-09-30
0001441236
us-gaap:RestrictedStockUnitsRSUMember
2021-07-01
2021-09-30
0001441236
us-gaap:RestrictedStockUnitsRSUMember
2021-01-01
2021-09-30
0001441236
us-gaap:PerformanceSharesMember
2022-07-01
2022-09-30
0001441236
us-gaap:PerformanceSharesMember
2021-07-01
2021-09-30
0001441236
us-gaap:PerformanceSharesMember
2021-01-01
2021-09-30
0001441236
us-gaap:StockOptionMember
2022-07-01
2022-09-30
0001441236
us-gaap:StockOptionMember
2021-07-01
2021-09-30
0001441236
us-gaap:StockOptionMember
2022-01-01
2022-09-30
0001441236
us-gaap:StockOptionMember
2021-01-01
2021-09-30
0001441236
clw:PulpAndPaperboardMember
2022-07-01
2022-09-30
0001441236
clw:PulpAndPaperboardMember
2021-07-01
2021-09-30
0001441236
clw:PulpAndPaperboardMember
2022-01-01
2022-09-30
0001441236
clw:PulpAndPaperboardMember
2021-01-01
2021-09-30
0001441236
clw:ConsumerProductsMember
2022-07-01
2022-09-30
0001441236
clw:ConsumerProductsMember
2021-07-01
2021-09-30
0001441236
clw:ConsumerProductsMember
2022-01-01
2022-09-30
0001441236
clw:ConsumerProductsMember
2021-01-01
2021-09-30
0001441236
us-gaap:IntersegmentEliminationMember
2022-07-01
2022-09-30
0001441236
us-gaap:IntersegmentEliminationMember
2021-07-01
2021-09-30
0001441236
us-gaap:IntersegmentEliminationMember
2022-01-01
2022-09-30
0001441236
us-gaap:IntersegmentEliminationMember
2021-01-01
2021-09-30
0001441236
us-gaap:CorporateNonSegmentMember
2022-07-01
2022-09-30
0001441236
us-gaap:CorporateNonSegmentMember
2021-07-01
2021-09-30
0001441236
us-gaap:CorporateNonSegmentMember
2022-01-01
2022-09-30
0001441236
us-gaap:CorporateNonSegmentMember
2021-01-01
2021-09-30
0001441236
clw:PaperboardDomain
2022-07-01
2022-09-30
0001441236
clw:PaperboardDomain
2021-07-01
2021-09-30
0001441236
clw:PaperboardDomain
2022-01-01
2022-09-30
0001441236
clw:PaperboardDomain
2021-01-01
2021-09-30
0001441236
clw:RetailtissueDomain
2022-07-01
2022-09-30
0001441236
clw:RetailtissueDomain
2021-07-01
2021-09-30
0001441236
clw:RetailtissueDomain
2022-01-01
2022-09-30
0001441236
clw:RetailtissueDomain
2021-01-01
2021-09-30
0001441236
clw:NonretailtissueDomain
2022-07-01
2022-09-30
0001441236
clw:NonretailtissueDomain
2021-07-01
2021-09-30
0001441236
clw:NonretailtissueDomain
2022-01-01
2022-09-30
0001441236
clw:NonretailtissueDomain
2021-01-01
2021-09-30
0001441236
clw:PulpDomain
2022-07-01
2022-09-30
0001441236
clw:PulpDomain
2021-07-01
2021-09-30
0001441236
clw:PulpDomain
2022-01-01
2022-09-30
0001441236
clw:PulpDomain
2021-01-01
2021-09-30
0001441236
clw:OtherDomain
2022-07-01
2022-09-30
0001441236
clw:OtherDomain
2021-07-01
2021-09-30
0001441236
clw:OtherDomain
2022-01-01
2022-09-30
0001441236
clw:OtherDomain
2021-01-01
2021-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
10-Q
(Mark One)
ý
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended
September 30, 2022
or
¨
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from
to
Commission File Number:
001-34146
CLEARWATER PAPER CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
20-3594554
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
601 West Riverside,
Suite 1100
99201
Spokane,
WA
(Address of principal executive offices)
(Zip Code)
(
509
)
344-5900
(Registrant’s telephone number, including area code)
__________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
CLW
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
ý
No
¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
ý
No
¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
¨
Accelerated filer
ý
Non-accelerated filer
¨
Smaller reporting company
¨
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
¨
No
ý
The number of shares of common stock of the registrant outstanding as of October 28, 2022 was
16,761,869
.
FORWARD-LOOKING STATEMENTS
Our disclosure and analysis in this report contains, in addition to historical information, certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding; inventory levels; accounting standards; borrowings and credit facilities; our operations and expectations; cash flows; capital expenditures; disclosure controls; compliance with our loan and financing agreements; tax rates; operating costs; selling, general and administrative expenses; liquidity; debt repayment; stockholder equity; interest rate risk; expected inflation costs for 2022; interest expenses; and legal proceedings. Words such as “anticipate,” “expect,” “intend,” “plan,” “target,” “project,” “believe,” “schedule,” “estimate,” “may,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on management’s current expectations, estimates, assumptions and projections that are subject to change. Our actual results of operations may differ materially from those expressed or implied by the forward-looking statements contained in this report. Important factors that could cause or contribute to such differences in operating results include those risks discussed in Item 1A “Risk Factors” in our 2021 Form 10-K, as well as the following:
•
•
competitive pricing pressures for our products, including as a result of increased capacity as additional manufacturing facilities are operated by our competitors and the impact of foreign currency fluctuations on the pricing of products globally;
•
customer acceptance and timing and quantity of purchases of our tissue products, including the existence of sufficient demand for and the quality of tissue produced by our expanded Shelby, North Carolina operations;
•
the loss of, changes in prices in regard to, or reduction in, orders from a significant customer;
•
changes in the cost and availability of wood fiber and wood pulp;
•
changes in freight costs and disruptions in transportation services;
•
changes in customer product preferences and competitors' product offerings;
•
cyber-security risks;
•
larger competitors having operational, financial and other advantages;
•
consolidation and vertical integration of converting operations in the paperboard industry;
•
our ability to successfully implement our operational efficiencies and cost savings strategies, along with related capital projects;
•
changes in the U.S. and international economies and in general economic conditions in the regions and industries in which we operate;
•
manufacturing or operating disruptions, including IT system and IT system implementation failures, equipment malfunctions and damage to our manufacturing facilities;
•
changes in costs for and availability of packaging supplies, chemicals, energy and maintenance and repairs;
•
labor disruptions;
•
cyclical industry conditions;
•
impact of the COVID-19 pandemic on our operations, our suppliers' operations and our customer demand;
•
changes in expenses, required contributions and potential withdrawal costs associated with our pension plans;
•
environmental liabilities or expenditures and climate change;
•
reliance on a limited number of third-party suppliers for raw materials;
•
our ability to attract, motivate, train and retain qualified and key personnel;
•
our substantial indebtedness and ability to service our debt obligations and restrictions on our business from debt covenants and terms;
•
changes in our banking relations and our customer supply chain financing;
•
negative changes in our credit agency ratings; and
•
changes in laws, regulations or industry standards affecting our business.
Forward-looking statements contained in this report present management’s views only as of the date of this report. Except as required under applicable law, we do not intend to issue updates concerning any future revisions of management’s views to reflect events or circumstances occurring after the date of this report. You are advised, however, to consult any further disclosures we make on related subjects in our quarterly reports on Form 10-Q and current reports on Form 8-K filed with the Securities and Exchange Commission, or SEC.
Table of Contents
Page
Number
PART I.
FINANCIAL INFORMATION
ITEM 1.
Consolidated Financial Statements (Unaudited)
Consolidated Balance Sheets
2
Consolidated Statements of Operations
3
Consolidated Statements of Comprehensive Income (Loss)
4
Consolidated Statements of Cash Flows
5
Consolidated Statements of Stockholders' Equity
6
Notes to Consolidated Financial Statements
8
ITEM 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
15
ITEM 3.
Quantitative and Qualitative Disclosures About Market Risk
21
ITEM 4.
Controls and Procedures
22
PART II.
OTHER INFORMATION
ITEM 1.
Legal Proceedings
23
ITEM 1A.
Risk Factors
23
ITEM 2.
Unregistered Sales of Equity Securities and Uses of Proceeds
23
ITEM 6.
Exhibits
24
Part I: Financial Information
ITEM 1.
Consolidated Financial Statements
CLEARWATER PAPER CORPORATION
Consolidated Balance Sheets
(Unaudited)
(In millions, except share data)
September 30, 2022
December 31, 2021
Assets
Current assets:
Cash and cash equivalents
$
50.8
$
25.2
Receivables, net of allowance for current expected credit losses
180.4
167.4
Inventories, net
326.8
277.7
Other current assets
12.1
16.9
Total current assets
570.2
487.2
Property, plant and equipment
2,968.6
2,961.5
Accumulated depreciation
(
1,945.4
)
(
1,879.7
)
Property, plant and equipment, net
1,023.1
1,081.8
Other assets, net
110.3
121.1
Total assets
$
1,703.6
$
1,690.1
Liabilities and stockholders' equity
Current liabilities:
Current portion of long-term debt
$
1.0
$
1.6
Accounts payable and accrued liabilities
294.1
252.5
Total current liabilities
295.1
254.1
Long-term debt
564.9
637.6
Liability for pension and other postretirement employee benefits
71.3
73.6
Deferred tax liabilities and other long-term obligations
203.1
213.1
Total liabilities
1,134.4
1,178.3
Stockholders’ equity:
Preferred stock, par value $
0.0001
per share,
5,000,000
authorized shares,
no
shares issued
—
—
Common stock, par value $
0.0001
per share,
100,000,000
authorized shares,
16,761,869
and
16,692,102
shares issued
—
—
Additional paid-in capital
25.7
23.6
Retained earnings
582.7
530.7
Accumulated other comprehensive loss, net of tax
(
39.1
)
(
42.6
)
Total stockholders' equity
569.2
511.7
Total liabilities and stockholders' equity
$
1,703.6
$
1,690.1
The accompanying notes are an integral part of these consolidated financial statements.
2
CLEARWATER PAPER CORPORATION
Consolidated Statements of Operations
(Unaudited)
Quarter Ended September 30,
Nine Months Ended September 30,
(In millions, except per-share data)
2022
2021
2022
2021
Net sales
$
538.8
$
450.5
$
1,553.3
$
1,282.8
Costs and expenses:
Cost of sales
454.8
398.2
1,332.0
1,160.9
Selling, general and administrative expenses
32.9
28.3
99.6
82.5
Other operating charges, net
2.2
10.2
8.5
55.1
Total operating costs and expenses
489.9
436.7
1,440.0
1,298.5
Income (loss) from operations
48.9
13.8
113.3
(
15.6
)
Interest expense, net
(
8.0
)
(
8.9
)
(
27.3
)
(
27.5
)
Debt retirement costs
—
(
0.5
)
(
0.5
)
(
0.5
)
Other non-operating expense
(
1.4
)
(
2.8
)
(
4.3
)
(
7.8
)
Total non-operating expense
(
9.4
)
(
12.2
)
(
32.1
)
(
35.7
)
Income (loss) before income taxes
39.5
1.7
81.2
(
51.4
)
Income tax provision (benefit)
18.9
(
0.3
)
29.3
(
13.8
)
Net income (loss)
$
20.6
$
1.9
$
51.9
$
(
37.6
)
Net income (loss) per common share:
Basic
$
1.23
$
0.12
$
3.09
$
(
2.25
)
Diluted
1.21
0.11
3.04
(
2.25
)
Average shares of common stock used to compute net income (loss) per share:
(in thousands)
Basic
16,754
16,687
16,777
16,689
Diluted
17,093
16,971
17,085
16,689
The accompanying notes are an integral part of these consolidated financial statements.
3
CLEARWATER PAPER CORPORATION
Consolidated Statements of Comprehensive Income (loss)
(Unaudited)
Quarter Ended September 30,
Nine Months Ended September 30,
(In millions)
2022
2021
2022
2021
Net income (loss)
$
20.6
$
1.9
$
51.9
$
(
37.6
)
Other comprehensive income (loss):
Defined benefit pension and other postretirement employee benefits:
Net loss arising during the period, net of tax of $
—
, $(
1.0
), $
—
,$(
1.0
)
—
(
2.8
)
—
(
2.8
)
Amortization of actuarial loss included in net periodic cost, net of tax of $
0.4
, $
0.7
, $
1.2
, and $
2.0
1.1
2.0
3.5
5.8
Other comprehensive income (loss), net of tax
1.1
(
0.8
)
3.5
3.0
Comprehensive income (loss)
$
21.8
$
1.1
$
55.4
$
(
34.6
)
The accompanying notes are an integral part of these consolidated financial statements.
4
CLEARWATER PAPER CORPORATION
Consolidated Statements of Cash Flows
(Unaudited)
Quarter Ended September 30,
Nine Months Ended September 30,
(In millions)
2022
2021
2022
2021
Operating activities
Net income (loss)
$
20.6
$
1.9
$
51.9
$
(
37.6
)
Adjustments to reconcile net income (loss) to net cash flows provided by operating activities:
Depreciation and amortization
26.2
25.9
77.4
79.6
Equity-based compensation expense
4.0
3.8
9.6
6.9
Deferred taxes
(
1.6
)
2.4
(
5.8
)
(
19.4
)
Defined benefit pension and other postretirement employee benefits
0.7
2.1
2.2
5.3
Amortization of deferred debt costs and debt retirement
0.5
1.0
1.8
1.9
Loss on sale or impairment associated with assets
1.2
—
5.8
37.1
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable
4.2
(
12.9
)
(
17.6
)
(
0.1
)
Increase in inventory
(
39.2
)
(
3.5
)
(
49.1
)
(
28.3
)
Decrease in other current assets
1.4
0.9
5.6
5.3
Increase (decrease) in accounts payable and accrued liabilities
(
4.4
)
(
4.8
)
50.0
13.8
Other, net
(
0.3
)
(
0.5
)
1.1
—
Net cash flows provided by operating activities
13.3
16.3
132.8
64.4
Investing activities
Additions to property, plant and equipment, net
(
6.7
)
(
8.9
)
(
19.9
)
(
29.9
)
Net cash flows used in investing activities
(
6.7
)
(
8.9
)
(
19.9
)
(
29.9
)
Financing activities
Repayments of long-term debt
(
25.3
)
(
40.5
)
(
80.8
)
(
41.3
)
Taxes paid related to net share settlement of equity awards
—
—
(
2.5
)
(
1.7
)
Repurchases of common stock
(
1.0
)
—
(
4.9
)
—
Other
0.7
—
0.7
0.5
Net cash flows used in financing activities
(
25.7
)
(
40.5
)
(
87.6
)
(
42.5
)
Increase (decrease) in cash, cash equivalents and restricted cash
(
19.1
)
(
33.1
)
25.3
(
8.1
)
Cash, cash equivalents and restricted cash at beginning of period
70.6
62.0
26.2
36.9
Cash, cash equivalents and restricted cash at end of period
$
51.5
$
28.9
$
51.5
$
28.9
Supplemental disclosures of cash flow information
Cash paid for interest, net of amounts capitalized
$
15.4
$
15.9
$
32.3
$
34.6
Cash paid (received) for income taxes
$
12.9
$
1.0
$
25.4
$
(
8.3
)
Cash, cash equivalents, and restricted cash
Cash and cash equivalents
$
50.8
$
27.8
$
50.8
$
27.8
Restricted cash included in other current assets and other assets, net
0.7
1.1
0.7
1.1
Total cash, cash equivalents and restricted cash
$
51.5
$
28.9
$
51.5
$
28.9
The accompanying notes are an integral part of these consolidated financial statements.
5
CLEARWATER PAPER CORPORATION
Consolidated Statements of Stockholders’ Equity
(Unaudited)
Common Stock
Additional Paid-In Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Total
Stockholders'
Equity
(In millions, except share amounts which are in thousands)
Shares
Amount
Balance at December 31, 2020
16,572
$
—
$
16.6
$
558.8
$
(
54.3
)
$
521.1
Net income
—
—
—
12.1
—
12.1
Stock-based compensation expense
—
—
2.0
—
—
2.0
Issuance of shares under stock plans, net
105
—
(
1.1
)
—
—
(
1.1
)
Pension and other postretirement employee benefits, net of tax of $
0.7
—
—
—
—
1.9
1.9
Balance at March 31, 2021
16,678
$
—
$
17.6
$
570.9
$
(
52.4
)
$
536.1
Net loss
—
—
—
(
51.6
)
—
(
51.6
)
Stock-based compensation expense
—
—
1.9
—
1.9
Issuance of shares under stock plans, net
7
—
(
0.1
)
—
—
(
0.1
)
Pension and other postretirement employee benefits, net of tax of $
0.7
—
—
—
—
1.9
1.9
Balance at June 30, 2021
16,685
$
—
$
19.3
$
519.2
$
(
50.5
)
$
488.1
Net income
—
—
—
1.9
—
1.9
Stock-based compensation expense
—
—
2.4
—
—
2.4
Issuance of shares under stock plans, net
1
—
—
—
—
—
Pension and other postretirement employee benefits, net of tax of $(
0.3
)
—
—
—
—
(
0.8
)
(
0.8
)
Balance at September 30, 2021
16,687
$
—
$
21.7
$
521.2
$
(
51.3
)
$
491.6
6
Common Stock
Additional Paid-In Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Total
Stockholders'
Equity
(In millions, except share amounts which are in thousands)
Shares
Amount
Balance at December 31, 2021
16,692
$
—
$
23.6
$
530.7
$
(
42.6
)
$
511.7
Net income
—
—
—
16.6
—
16.6
Stock-based compensation expense
—
—
2.0
—
—
2.0
Issuance of shares under stock plans, net
119
—
(
1.5
)
—
—
(
1.5
)
Pension and other postretirement employee benefits, net of tax of $
0.4
—
—
—
—
1.1
1.1
Balance at March 31, 2022
16,811
$
—
$
24.1
$
547.3
$
(
41.4
)
$
530.0
Net income
—
—
—
14.7
—
14.7
Stock-based compensation expense
—
—
3.8
—
—
3.8
Issuance of shares under stock plans, net
78
—
(
1.0
)
—
—
(
1.0
)
Pension and other postretirement employee benefits, net of tax of $
0.4
—
—
—
—
1.1
1.1
Repurchases of common stock
(
119
)
—
(
3.9
)
—
—
(
3.9
)
Balance at June 30, 2022
16,770
$
—
$
23.0
$
562.0
$
(
40.3
)
$
544.7
Net income
—
—
—
20.6
—
20.6
Stock-based compensation expense
—
—
3.0
—
—
3.0
Issuance of shares under stock plans, net
23
—
0.7
—
—
0.7
Pension and other postretirement employee benefits, net of tax of $
0.4
—
—
—
—
1.1
1.1
Repurchases of common stock
(
31
)
—
(
1.0
)
—
—
(
1.0
)
Balance at September 30, 2022
16,762
$
—
$
25.7
$
582.7
$
(
39.1
)
$
569.2
The accompanying notes are an integral part of these consolidated financial statements.
7
Clearwater Paper Corporation
Notes to Consolidated Financial Statements
(Unaudited)
Note 1
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments) necessary to present fairly, in all material respects, the consolidated financial position, results of operations, stockholders' equity and cash flows for us and our subsidiaries for the interim periods presented. Results of operations for interim periods are not necessarily indicative of results to be expected for an entire year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021. Certain amounts have been reclassified from the prior year presentation for consistency. All dollar amounts are shown in millions, except per share.
Note 2 Recently Adopted and Recently Issued Accounting Standards
In November 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2021-10,
Disclosures by Business Entities About Government Assistance (Topic 832),
which requires disclosures about certain types of government assistance including the nature of the assistance, related accounting policies, and the effect on an entity's financial statements. The new standard is effective for annual periods beginning after December 15, 2021 with prospective or retrospective adoption permitted. This ASU was adopted prospectively as of January 1, 2022 and did not have a material impact on our consolidated financial statements.
In September 2022, the FASB issued ASU No. 2022-04,
Liabilities—Supplier Finance Programs (Subtopic 405-50)
. This standard requires disclosure of the key terms of outstanding supplier finance programs and a roll forward of the related obligations. The new standard does not affect the recognition, measurement or financial statement presentation of supplier finance program obligations. The ASU becomes effective January 1, 2023, except for the roll forward requirement, which becomes effective January 1, 2024. Upon adoption, we may be required to include additional disclosures to the extent we have material supplier finance program obligations.
Note 3
Fair Value Measurements
Carrying amounts reported on the balance sheet for cash and cash equivalents, restricted cash, accounts receivable and accounts payable approximate fair value due to the short-term maturity of these instruments. During the nine months ended September 30, 2022, we repurchased $
30.0
million of our 2014 Notes at slightly below par resulting in an immaterial gain within our debt retirement costs.
The fair value of our debt is included in the following table:
September 30, 2022
December 31, 2021
Term loan maturing 2026, variable interest rate
$
—
$
49.8
2014 Notes, maturing 2025, fixed interest rate
265.3
324.6
2020 Notes, maturing 2028, fixed interest rate
237.9
278.9
$
503.2
$
653.3
Note 4
Receivables
Receivables consist of:
September 30, 2022
December 31, 2021
Trade accounts receivable
$
172.1
$
154.1
Allowance for current expected credit losses
(
1.4
)
(
1.4
)
Unbilled receivables
6.3
7.2
Taxes receivable
1.4
6.1
Other
2.0
1.4
$
180.4
$
167.4
8
Note 5
Inventories
Our inventories are stated at the lower of net realizable value or current cost using the average cost method and consist of:
September 30, 2022
December 31, 2021
Logs, chips and sawdust
$
18.2
$
13.7
Pulp
23.1
15.9
Paperboard and tissue products
175.2
148.0
Materials and supplies
110.4
100.1
$
326.8
$
277.7
Note 6
Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities consist of:
September 30, 2022
December 31, 2021
Trade payables
$
189.0
$
156.2
Accrued compensation
43.5
29.3
Operating lease liabilities
13.8
16.1
Accrued interest
4.3
12.0
Accrued taxes other than income
13.4
10.9
Income taxes payable
6.4
0.6
Other accrued liabilities
23.8
27.3
$
294.1
$
252.5
Included in accounts payable and accrued liabilities are $
7.3
million and $
11.0
million related to capital expenditures that had not yet been paid as of September 30, 2022 and December 31, 2021.
Note 7
Income Taxes
For interim periods, accounting standards require that income tax expense be determined by applying the estimated annual effective income tax rate to year-to-date results, unless this method does not result in a reliable estimate of year-to-date income tax expense. Each period, the income tax accrual is adjusted to the latest estimate and the difference from the previously accrued year-to-date balance is adjusted to the current quarter.
For the nine months ended September 30, 2022, our income tax provision was $
29.3
million as compared to a benefit of $
13.8
million in the same period in 2021. Our effective tax rate for the nine months ended September 30, 2022 was
36.1
%, which varied from the U.S. federal statutory tax rate of
21.0
% primarily due to adjustments in tax positions under audit related to the disallowance of a previously taken federal tax credits based upon interpretation of the law, the effects of state taxes, and nondeductible compensation. Our effective tax rate for the nine months ended September 30, 2021 was
26.8
%, which varied from the U.S. federal statutory tax rate of
21.0
% primarily due to the effects of state taxes and nondeductible compensation.
Note 8
Other Operating Charges
The major components of “Other operating charges, net” in the Consolidated Statements of Operations for the quarter and nine months ended September 30, 2022 and 2021 are reflected in the table below and described in the paragraphs following the table. These items are considered outside of our core operations.
Quarter Ended September 30,
Nine Months Ended September 30,
2022
2021
2022
2021
Reorganization and other expenses
$
—
$
3.4
$
1.6
$
7.3
Costs associated with mill closure
—
5.4
0.4
47.1
Impairment of equipment
1.2
—
5.8
—
Directors' equity-based compensation expense
1.0
1.4
0.7
0.6
$
2.2
$
10.2
$
8.5
$
55.1
9
2022
During the third quarter of 2022, we recorded $
2.2
million of expenses in "Other operating charges, net." The components of the expense include:
•
loss of $
1.2
million associated with the impairment of equipment no longer being used; and
•
expense of $
1.0
million relating to directors' equity based compensation which is remeasured each period based upon changes in our stock price.
During the second quarter of 2022, we recorded $
5.7
million of expenses in "Other operating charges, net." The components of the expense include:
•
loss of $
4.6
million associated with the impairment of equipment previously located at a closed facility which will not be re-installed; and
•
expense of $
1.1
million relating to directors' equity based compensation which is remeasured each period based upon changes in our stock price.
During the first quarter of 2022, we recorded $
0.5
million of expenses in "Other operating charges, net." The components of the expense include:
•
expense of $
1.5
million related to reorganization and other expenses including consulting fees associated with our efforts to achieve long-term performance improvements;
•
expense of $
0.4
million associated with mill closure costs; and
•
reversal of expense of $
1.4
million relating to directors' equity based compensation which is remeasured each period based upon changes in our stock price.
2021
During the third quarter of 2021, we recorded $
10.2
million of expenses in "Other operating charges, net." The components of the expense include:
•
expense of $
5.4
million associated with mill closure related to severance and other related closure costs;
•
expense of $
3.4
million related to reorganization and other expenses including consulting fees associated with our efforts to achieve long-term performance improvements, and
•
expense of $
1.4
million relating to directors' equity based compensation which is remeasured each period based upon changes in our stock price.
During the second quarter of 2021, we recorded $
44.5
million of expenses in "Other operating charges, net." The components of the expense include:
•
expense of $
41.7
million associated with mill closure including $
36.9
million associated with the impairment of property, plant and equipment and certain inventory and an expense of $
4.9
million associated with severance and other related closure costs;
•
expense of $
4.0
million related to reorganization and other expenses including severance and consulting fees associated with our efforts to achieve long-term performance improvements; and
•
reversal of expense of $
1.1
million relating to directors' equity based compensation which is remeasured each period based upon changes in our stock price.
During the first quarter of 2021, we recorded $
0.4
million of expenses in "Other operating charges, net." The components of the expense include:
•
expense of $
0.4
million relating to directors' equity based compensation which is remeasured each period based upon changes in our stock price.
Note 9
Non-Operating Expense
The components of “Non-operating expense” in the Consolidated Statements of Operations for the quarter and nine months ended September 30, 2022 and 2021 are reflected in the table below:
10
Quarter Ended September 30,
Nine Months Ended September 30,
2022
2021
2022
2021
Interest expense
$
(
8.0
)
$
(
8.4
)
$
(
26.6
)
$
(
26.7
)
Amortization of debt issuance costs
(
0.4
)
(
0.5
)
(
1.2
)
(
1.4
)
Interest income
0.3
—
0.4
0.6
Interest expense, net
(
8.0
)
(
8.9
)
(
27.3
)
(
27.5
)
Debt retirement costs
—
(
0.5
)
(
0.5
)
(
0.5
)
Non-operating pension and other postretirement employee benefits expense
(
1.4
)
(
2.8
)
(
4.3
)
(
7.8
)
Total non-operating expense
$
(
9.4
)
$
(
12.2
)
$
(
32.1
)
$
(
35.7
)
Note 10
Retirement Plans and Postretirement Benefits
The following table details the components of net periodic cost of our company-sponsored pension and other postretirement employee benefit plans for the periods presented:
Quarter Ended September 30,
Nine Months Ended September 30,
Pension Benefit Plans
2022
2021
2022
2021
Service cost
$
0.5
$
0.4
$
1.6
$
1.4
Interest cost
2.2
2.1
6.6
6.3
Expected return on plan assets
(
2.8
)
(
2.6
)
(
8.5
)
(
7.9
)
Amortization of actuarial loss
1.5
2.5
4.6
7.7
Net periodic cost
$
1.5
$
2.4
$
4.4
$
7.4
Quarter Ended September 30,
Nine Months Ended September 30,
Other Postretirement Employee Benefit Plans
2022
2021
2022
2021
Service cost
$
0.1
$
0.2
$
0.3
$
0.3
Interest cost
0.5
0.6
1.5
1.5
Amortization of actuarial loss
—
0.2
—
0.2
Net periodic cost
$
0.6
$
1.0
$
1.8
$
2.0
We record the service component of net periodic cost as part of "Cost of sales" and "Selling, general, and administrative expenses", while the non-service components of net periodic cost are recorded to "Other non-operating expense" on our Consolidated Statements of Operations. For the quarter and nine months ended September 30, 2022, we recorded $
0.5
million and $
1.6
million to "Cost of sales" and $
0.1
million and $
0.3
million to "Selling, general, and administrative expenses". For the quarter and nine months ended September 30, 2021, we recorded $
0.6
million and $
1.5
million to "Cost of sales" and less than $
0.1
million and $
0.2
million to "Selling, general, and administrative expenses".
11
Note 11
Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss, net of tax, is comprised of the following:
Pension Plan Adjustments
Other Post Retirement Employee Benefit Plan Adjustments
Total
Balance at December 31, 2020
$
(
54.5
)
$
0.2
$
(
54.3
)
Other comprehensive income (loss) before reclassifications
—
(
2.8
)
(
2.8
)
Amounts reclassified from accumulated other comprehensive loss
5.7
0.2
5.8
Balance at September 30, 2021
$
(
48.9
)
$
(
2.4
)
$
(
51.3
)
Balance at December 31, 2021
$
(
42.8
)
$
0.3
$
(
42.6
)
Amounts reclassified from accumulated other comprehensive loss
3.5
—
3.5
Balance at September 30, 2022
$
(
39.4
)
$
0.3
$
(
39.1
)
Note 12
Stockholders' Equity
Common Stock Plans
We have stock-based compensation plans under which restricted stock awards and stock options are outstanding or granted subject to time or performance vesting requirements. At September 30, 2022, approximately
0.9
million shares were available for future issuance under our current plan.
Quarter Ended September 30,
Nine Months Ended September 30,
2022
2021
2022
2021
Total stock-based compensation expense
$
4.0
$
3.8
$
9.6
$
6.9
Income tax benefit related to stock-based compensation
$
1.0
$
1.0
$
2.4
$
1.8
Impact on cash flow due to taxes paid related to net share settlement of equity awards
$
—
$
—
$
2.5
$
1.7
At September 30, 2022, there was $
16.4
million of total unrecognized compensation cost related to outstanding restricted stock unit awards.
During the nine months ended September 30, 2022, we granted
220,518
restricted stock units (time vesting) at an average grant date fair value of $
29.52
per share and
103,067
restricted stock units (performance vesting) at an average grant date fair value of $
30.55
per share.
12
Note 13
Earnings per Share
Basic income per share is based on the weighted-average number of shares of common stock outstanding. Diluted income per share is based upon the weighted-average number of shares of common stock outstanding plus all potentially dilutive securities that were assumed to be converted into common shares at the beginning of the period under the treasury stock method. This method requires the effect of potentially dilutive common stock equivalents be excluded from the calculation of diluted earnings per share for the periods in which net losses are reported because the effect is anti-dilutive.
Quarter Ended September 30,
Nine Months Ended September 30,
(In thousands)
2022
2021
2022
2021
Basic weighted-average common shares outstanding
16,754
16,687
16,777
16,689
Incremental shares due to:
Stock-based awards
197
186
181
—
Performance shares
137
98
127
—
Stock options
6
—
—
—
Diluted weighted-average common shares outstanding
17,093
16,971
17,085
16,689
Shares excluded from the computation of diluted earnings per share were
0.2
million and
0.3
million for the quarter and nine months ended September 30, 2022 as they were either antidilutive (not in-the-money) or the required performance conditions were not met. Shares excluded from the computation of diluted earnings per share were
0.3
million for the quarter ended September 30, 2021 as they were either antidilutive (not in-the-money) or the required performance conditions were not met and
0.6
million for the nine months ended September 30, 2021 due to our reporting a net loss for the period
.
Note 14
Segment Information
We operate in two segments: Pulp and Paperboard and Consumer Products. Our business units have been aggregated into these two segments based upon the similarity of economic characteristics, customers and distribution methods. Our results of operations are summarized below for each of these segments separately. Segment information was prepared in accordance with the same accounting principles as those described in Note 1 of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2021.
Quarter Ended September 30,
Nine Months Ended September 30,
2022
2021
2022
2021
Segment net sales:
Pulp and Paperboard
$
300.8
$
237.5
$
862.8
$
684.6
Consumer Products
241.0
214.2
696.1
603.2
Eliminations
(
3.0
)
(
1.2
)
(
5.6
)
(
5.0
)
Net sales
$
538.8
$
450.5
$
1,553.3
$
1,282.8
Operating income (loss):
Pulp and Paperboard
$
63.7
$
34.6
$
165.9
$
72.6
Consumer Products
5.2
3.7
9.6
11.5
Corporate and eliminations
(
17.8
)
(
14.3
)
(
53.8
)
(
44.8
)
Other operating charges, net
(
2.2
)
(
10.2
)
(
8.5
)
(
55.1
)
Income (loss) from operations
$
48.9
$
13.8
$
113.3
$
(
15.6
)
13
Net sales, classified by major products were as follows:
Quarter Ended September 30,
Nine Months Ended September 30,
2022
2021
2022
2021
Major products:
Paperboard
$
292.7
$
224.1
$
834.6
$
648.8
Retail tissue
237.1
208.3
682.3
572.9
Away-from-home tissue
1
—
1.9
—
16.3
Pulp
4.6
8.4
18.5
23.9
Other
7.3
8.9
23.5
26.1
Eliminations
(
3.0
)
(
1.2
)
(
5.6
)
(
5.0
)
Total net sales
$
538.8
$
450.5
$
1,553.3
$
1,282.8
1
In the third quarter of 2021, we exited our away-from-home business with the shutdown of our Neenah, Wisconsin site.
14
ITEM 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with the Consolidated Financial Statements and Notes thereto included herein and our audited Consolidated Financial Statements and Notes thereto for the year ended December 31, 2021, as well as the information under the heading “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” that are part of our Annual Report on Form 10-K for the year ended December 31, 2021.
OVERVIEW
Executive Summary
We recorded an increase of 20% in net sales to $538.8 million for the quarter ended September 30, 2022 compared to $450.5 million for the quarter ended September 30, 2021. We recorded net income for the quarter ended September 30, 2022 of $20.6 million, or $1.21 per diluted share, compared to a net income of $1.9 million or $0.11 per diluted share in the quarter ended September 30, 2021. We recorded Adjusted EBITDA for the quarter ended September 30, 2022 of $77.3 million compared to $49.9 million in the quarter ended September 30, 2021.
We recorded an increase of 21% in net sales to $1.6 billion for the nine months ended September 30, 2022 compared to $1.3 billion for the nine months ended September 30, 2021. We recorded net income for the nine months ended September 30, 2022 of $51.9 million, or $3.04 per diluted share, compared to a net loss of $37.6 million or $2.25 per diluted share in the nine months ended September 30, 2021. We recorded Adjusted EBITDA for the nine months ended September 30, 2022 of $199.2 million compared to $119.0 million in the nine months ended September 30, 2021.
Included in net loss for the nine months ended September 30, 2021 is a loss related to the closure of our Neenah, Wisconsin facility of $47.1 million. The primary components of this loss include a $31.6 million impairment to property plant and equipment, a $5.3 million write-down to inventory and $10.3 million of cash expenses for our employees including severance and other related closure costs.
See discussion on segment level results regarding net sales, operating results and Adjusted EBITDA in “Our Operating Results” below.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The preparation of financial statements in accordance with generally accepted accounting principles (GAAP) requires our management to select and apply accounting policies that best provide the framework to report our results of operations and financial position. The selection and application of those policies requires management to make difficult, subjective and complex judgments concerning reported amounts of revenue and expenses during the reporting period and the reported amounts of assets and liabilities at the date of the financial statements. As a result, it is possible that materially different amounts would be reported under different conditions or using different assumptions.
As of September 30, 2022 there have been no significant changes with regard to the critical accounting policies and estimates disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021.
NON-GAAP MEASURES
In evaluating our business, we utilize several non-GAAP financial measures. A non-GAAP financial measure is generally defined by the SEC as one that purports to measure historical or future financial performance, financial position or cash flows, but excludes or includes amounts that would not be so excluded or included under applicable GAAP guidance. In this report on Form 10-Q, we disclose overall and segment income (loss) from operations before interest expense, net, other non-operating costs, taxes, depreciation and amortization, debt retirement costs, other operating charges, net, and Adjusted EBITDA which is a non-GAAP financial measure. Adjusted EBITDA is not a substitute for the GAAP measure of net income (loss) or for any other GAAP measures of operating performance.
We have included Adjusted EBITDA on a consolidated and segment basis in this report because we use them as important supplemental measures of our performance and believe that they are frequently used by securities analysts, investors and other interested persons in the evaluation of companies in our industry, some of which present Adjusted EBITDA when reporting their results. We also use Adjusted EBITDA to evaluate our performance as compared to other companies in our industry that have different financing and capital structures and/or tax rates. It should be noted that companies calculate Adjusted EBITDA differently and, therefore, our Adjusted EBITDA measures may not be comparable to Adjusted EBITDA reported by other companies. Our Adjusted EBITDA measures have material limitations as performance measures because they exclude interest expense, income tax provision and depreciation and amortization which are necessary to operate our business or which we otherwise incur or experience in connection with the operation of our business. In addition, we exclude other income and expense items which are outside of our core operations.
15
The following table provides our Adjusted EBITDA for the periods presented, as well as a reconciliation to net income (loss) and segment operating income (loss).
Quarter Ended September 30,
Nine Months Ended September 30,
(In millions)
2022
2021
2022
2021
Net income (loss)
$
20.6
$
1.9
$
51.9
$
(37.6)
Income tax provision (benefit)
18.9
(0.3)
29.3
(13.8)
Interest expense, net
8.0
8.9
27.3
27.5
Depreciation and amortization
26.2
25.9
77.4
79.6
Other operating charges, net
2.2
10.2
8.5
55.1
Debt retirement costs
—
0.5
0.5
0.5
Other non-operating expense
1.4
2.8
4.3
7.8
Adjusted EBITDA
$
77.3
$
49.9
$
199.2
$
119.0
Pulp and Paperboard segment income
$
63.7
$
34.6
$
165.9
$
72.6
Depreciation and amortization
9.3
8.9
27.8
26.9
Adjusted EBITDA Pulp and Paperboard segment
$
73.0
$
43.5
$
193.7
$
99.5
Consumer Products segment income
$
5.2
$
3.7
$
9.6
$
11.5
Depreciation and amortization
16.0
15.9
46.9
49.4
Adjusted EBITDA Consumer Products segment
$
21.2
$
19.6
$
56.6
$
60.9
Corporate and other expense
$
(17.8)
$
(14.3)
$
(53.8)
$
(44.8)
Depreciation and amortization
0.9
1.1
2.6
3.3
Adjusted EBITDA Corporate and other
$
(16.9)
$
(13.1)
$
(51.1)
$
(41.4)
Pulp and Paperboard segment
$
73.0
$
43.5
$
193.7
$
99.5
Consumer Products segment
21.2
19.6
56.6
60.9
Corporate and other
(16.9)
(13.1)
(51.1)
(41.4)
Adjusted EBITDA
$
77.3
$
49.9
$
199.2
$
119.0
16
OUR OPERATING RESULTS
Our results of operations for each of our segments are discussed below. See Note 14 "Segment Information" of the Notes to the Consolidated Financial Statements included in Item 1 of this report for further information regarding our segments.
Pulp and Paperboard
Quarter Ended September 30,
Nine Months Ended September 30,
(Dollars in millions, except per ton amounts)
2022
2021
Increase (decrease)
2022
2021
Increase (decrease)
Sales:
Paperboard
$
292.7
$
224.1
30.6
%
$
834.6
$
648.8
28.6
%
Pulp
4.6
8.4
(45.6)
%
18.5
23.9
(22.3)
%
Other
3.5
4.9
(29.2)
%
9.7
12.0
(19.5)
%
$
300.8
$
237.5
26.7
%
$
862.8
$
684.6
26.0
%
Operating income
$
63.7
$
34.6
83.9
%
$
165.9
$
72.6
128.5
%
Operating margin
21.2
%
14.6
%
19.2
%
10.6
%
Adjusted EBITDA
$
73.0
$
43.5
67.9
%
$
193.7
$
99.5
94.7
%
Adjusted EBITDA margin
24.3
%
18.3
%
22.5
%
14.5
%
Paperboard shipments (short tons)
208,298
203,439
2.4
%
625,557
610,702
2.4
%
Paperboard sales price (per short ton)
$
1,405
$
1,102
27.5
%
$
1,334
$
1,062
25.6
%
Sales volumes in our Pulp and Paperboard segment increased for the quarter and nine months ended September 30, 2022 compared to the same periods in the prior year due to increased demand. Additionally, product availability was limited during the quarter and first nine months of 2021, due to planned maintenance outages at our Cypress Bend, Arkansas facility in the third quarter of 2021 and our Lewiston, Idaho facility in the second quarter of 2021 and severe weather events during the first quarter of 2021. Sales prices increased in our Pulp and Paperboard segment for the quarter and nine month periods ended September 30, 2022 compared to the same periods in the prior year due to the impacts of our previously announced price increases.
Overall, the increase in operating income and Adjusted EBITDA for the quarter and nine month periods ended September 30, 2022 as compared to the same periods in the prior year was driven by higher sales prices and the absence of planned maintenance outages, partially offset by inflation.
17
Consumer Products
Quarter Ended September 30,
Nine Months Ended September 30,
(Dollars in millions, except per unit)
2022
2021
Increase (decrease)
2022
2021
Increase (decrease)
Sales:
Retail tissue
$
237.1
$
208.3
13.9
%
$
682.3
$
572.9
19.1
%
Away-from-home
1
—
1.9
(100.0)
%
—
16.3
(100.0)
%
Other
3.8
4.0
(4.2)
%
13.8
14.1
(1.8)
%
$
241.0
$
214.2
12.5
%
$
696.1
$
603.2
15.4
%
Operating income (loss)
$
5.2
$
3.7
42.5
%
$
9.6
$
11.5
(16.6)
%
Operating margin
2.2
%
1.7
%
1.4
%
1.9
%
Adjusted EBITDA
$
21.2
$
19.6
8.7
%
$
56.6
$
60.9
(7.2)
%
Adjusted EBITDA margin
8.8
%
9.1
%
8.1
%
10.1
%
Shipments (short tons)
Retail
76,938
76,237
0.9
%
228,968
208,496
9.8
%
Away-from-home
1
—
990
(100.0)
%
—
8,661
(100.0)
%
Other
2,322
4,751
(51.1)
%
10,010
13,947
(28.2)
%
79,260
81,978
(3.3)
%
238,978
231,104
3.4
%
Sales price (per short ton)
Retail
$
3,082
$
2,732
12.8
%
$
2,980
$
2,748
8.4
%
1
In the third quarter of 2021, we exited our away-from-home business with the shutdown of our Neenah, Wisconsin site.
Retail sales volumes in our Consumer Products segment increased for the quarter and nine months ended September 30, 2022 compared to the same periods in the prior year as consumer demand stabilized due to consumer buying patterns returning to pre-COVID levels as well as several new customer programs. Retail sales prices increased in our Consumer Products segment for the quarter and nine months ended September 30, 2022 compared to the same periods in the prior year due to our previously announced price increases and improved product mix.
Overall, the increase in operating income and Adjusted EBITDA for the quarter ended September 30, 2022 compared to the same period in the prior year was driven by higher sales prices partially offset by higher input costs, primarily in pulp and freight costs. The decrease in operating income and Adjusted EBITDA for the nine months September 30, 2022 compared to the same period in the prior year was driven by higher input costs, primarily in pulp and freight costs partially offset by higher sales prices and increased volume.
Corporate expenses
Corporate expenses for the quarter and nine months ended September 30, 2022 were $17.8 million and $53.8 million compared to $14.3 million and $44.8 million in the same periods in the prior year. The increase between periods is primarily related to the higher incentive compensation based upon higher than expected operating results. Corporate expenses primarily consist of corporate overhead such as wages and benefits, professional fees, insurance and other expenses for corporate functions including certain executive officers, public company costs, information technology, financial services, environmental and safety, legal, supply management, human resources and other corporate functions not directly associated with the business operations.
Other operating charges
See Note 8 "Other operating charges" of the Notes to the Consolidated Financial Statements included in Item 1 of this report for additional information.
18
Interest expense
Interest expense for the quarter ended September 30, 2022 was $8.0 million as compared to $8.9 million in the same period in the prior year due to lower debt outstanding. Interest expense for the nine months ended September 30, 2022 was $27.3 million as compared to $27.5 million in the same period in prior year due to lower debt outstanding, partially offset by a one-time increase of $2.2 million associated with our capital leases. See Note 9 "Non-operating income (expense)" of the Notes to the Consolidated Financial Statements included in Item 1 of this report for additional information.
Inflation Reduction Act of 2022
On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on our current analysis of the provisions, we do not believe this legislation will have a material impact on our consolidated financial statements.
Potential impairments
We review from time to time possible dispositions or reorganization of various assets in light of current and anticipated economic and industry conditions, our strategic plan and other relevant factors. Because a determination to dispose or reorganize particular assets may require management to make assumptions regarding the transaction structure of the disposition or reorganization and to estimate the net sales proceeds, which may be less than previous estimates of undiscounted future net cash flows, we may be required to record impairment charges in connection with decisions to dispose of assets.
19
LIQUIDITY AND CAPITAL RESOURCES
Our principal sources of liquidity are existing cash balances, cash generated by our operations and our ability to borrow under such credit facilities as we may have in effect from time to time. Our principal uses of liquidity are paying the costs and expenses associated with our operations, servicing outstanding indebtedness and making capital expenditures. We may also from time to time, prepay or repurchase outstanding indebtedness (including by issuing new indebtedness subject to market conditions to refinance such outstanding indebtedness) or repurchase shares of our common stock or acquire assets or businesses that are complementary to our operations.
Operating Activities
Net cash flows provided by operating activities for the nine months ended September 30, 2022 were $132.8 million compared to $64.4 million for the nine months ended September 30, 2021. This increase was driven by improved operating performance offset by higher net cash tax payments and changes in working capital. Accounts receivable and accounts payable agings have remained relatively consistent with balances as of December 31, 2021.
Investing Activities
During the nine months ended September 30, 2022, net cash flows used in investing activities were $19.9 million compared to $29.9 million in the same period of the prior year. Included in the nine months ended September 30, 2022 is a $2.4 million refund associated with a capital project placed in service in prior years. Included in "Accounts payable and accrued liabilities" on our Consolidated Balance Sheets was $7.3 million and $8.9 million related to capital expenditures that had not yet been paid at September 30, 2022 and 2021.
Throughout 2022, we expect cash paid for capital expenditures to be approximately $30 million to $40 million.
Financing Activities
Net cash flows used by financing activities were $87.6 million for the nine months ended September 30, 2022
compared to
$42.5 million for the same period of 2021. The increase was due to $4.9 million used for common stock repurchases under our stock repurchase program, $50.0 million prepayment in full of our Term Loan Credit Agreement and $30.0 million in open market purchases of our 2014 Notes during the nine months ended September 30, 2022.
ABL Credit Agreement
The ABL Credit Agreement matures on July 26, 2024 and includes a $250 million revolving loan commitment, subject to borrowing base limitations based on a percentage of applicable eligible receivables and eligible inventory. Based upon our Consolidated Balance Sheet as of September 30, 2022, our borrowing base supported up to $250 million of availability under the line, of which no borrowings were outstanding and $3.7 million was utilized to issue letters of credit. We may, at our option, prepay any borrowings under the ABL Credit Agreement, in whole or in part, at any time and from time to time without premium or penalty (except in certain circumstances).
The ABL Credit Agreement also contains a financial covenant, which requires us to maintain a consolidated fixed charge coverage ratio of not less than 1.10 to 1.00, provided that the financial covenant under the ABL Credit Agreement is only applicable when unused availability falls below $25 million. As of September 30, 2022, our fixed charge coverage ratio was approximately 4.0x.
20
ITEM 3.
Quantitative and Qualitative Disclosures About Market Risk
Interest Rate Risk
Our exposure to market risks on financial instruments includes interest rate risk on our credit agreements. As of September 30, 2022, our Term Loan Credit Agreement was repaid in full and there were no borrowings outstanding under our ABL Credit Agreement.
21
ITEM 4.
Controls and Procedures
As of September 30, 2022, our Chief Executive Officer (CEO) and Chief Financial Officer (CFO) have carried out, with the participation of our Disclosure Committee and management, an evaluation of the effectiveness of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the Act). Based upon this evaluation, the CEO and CFO have concluded that our disclosure controls and procedures are effective to provide reasonable assurance that material information required to be disclosed by us in reports we file under the Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms and that information required to be disclosed by us in the reports we file or submit under the Act is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the quarter ended September 30, 2022 that has materially affected, or is likely to materially affect, our internal control over financial reporting.
22
Part II
ITEM 1.
Legal Proceedings
We may from time to time be involved in claims, proceedings and litigation arising from our business and property ownership. We believe, based on currently available information, that the results of such proceedings, in the aggregate, will not have a material adverse effect on our financial condition.
ITEM 1A.
Risk Factors
There are no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021. See Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021, entitled “Risk Factors.”
ITEM 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
On December 15, 2015, we announced that our Board of Directors had approved a stock repurchase program authorizing the repurchase of up to $100 million of our common stock. As of September 30, 2022, we had $24.9 million of authorization remaining. The repurchase program authorizes purchases of our common stock from time to time through open market purchases, negotiated transactions or other means, including accelerated stock repurchases and 10b5-1 trading plans in accordance with applicable securities laws and other restrictions. We have no obligation to repurchase stock under this program and may suspend or terminate the program at any time.
Period
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Program
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
July 1, 2022 to July 31, 2022
30,052
$
33.93
30,052
$
24.9
August 1, 2022 to August 31, 2022
480
$
35.02
480
$
24.9
September 1, 2022 to September 30, 2022
—
$
—
—
$
24.9
Total
30,532
$
33.95
30,532
Shares of common stock withheld as payment of withholding taxes and exercise prices in connection with the vesting or exercise of equity awards are not required to be disclosed under Item 703 of Regulation S-K and accordingly are excluded from the amounts in the table above.
23
ITEM 6. Exhibits
EXHIBIT
NUMBER
DESCRIPTION
31**
Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32**
Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C Section 1350.
101.INS
XBRL Instance Document
101.SCH
XBRL Taxonomy Extension Schema.
101.CAL
XBRL Taxonomy Extension Calculation Linkbase.
101.DEF
XBRL Taxonomy Extension Definition Linkbase.
101.LAB
XBRL Taxonomy Extension Label Linkbase.
101.PRE
XBRL Taxonomy Extension Presentation Linkbase.
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
**
In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 34-47986, the certifications furnished in Exhibit 32 hereto are deemed to accompany this Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CLEARWATER PAPER CORPORATION
(Registrant)
October 31, 2022
By:
/s/ ARSEN S. KITCH
Arsen S. Kitch
President, Chief Executive Officer and Director (Principal Executive Officer)
October 31, 2022
By:
/s/ MICHAEL J. MURPHY
Michael J. Murphy
Senior Vice President, Finance and Chief Financial Officer (Principal Financial Officer)
24